Eric L. Low
Haddington, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Hyperphagia severity is underestimated in adults with Bardet-Biedl syndrome - a mixed-method cross-sectional study in the United Kingdom.
Journal: Frontiers in endocrinology
Published: April 17, 2026
Pharmaceutical governance system for costly drugs through human rights due diligence.
Journal: BMJ (Clinical research ed.)
Published: November 11, 2025
Recommended methods for the collection of clinical expert judgment in rare diseases: Generating evidence to support reimbursement of orphan drugs.
Journal: International journal of technology assessment in health care
Published: October 07, 2025
An Attribution of Value Framework for Combination Treatments.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: September 07, 2023
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 05, 2022
Commentary: Advocating for patient and public involvement and engagement in health economic evaluation.
Journal: Research involvement and engagement
Published: July 25, 2022
Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.
Journal: Heart (British Cardiac Society)
Published: August 16, 2021
Letter of support from Eric Low, Director, Eric Low Consulting, Edinburgh, UK.
Journal: International journal of technology assessment in health care
Published: January 29, 2021
Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four Trial.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 09, 2020
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
Journal: British journal of haematology
Published: May 14, 2020
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Journal: Health technology assessment (Winchester, England)
Published: November 07, 2019
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: April 10, 2019
Last Updated: 09/26/2026